Radionuclide imaging in coronary artery disease.
The utility and limitations of radionuclide imaging in coronary artery disease are presented. Rationale for its usage is discussed in terms of pathophysiologic alterations of the heart and how the pharmacologic properties of these radiopharmaceutical agents can be used advantageously for assessment of such alterations.
D003327:Coronary Disease / Q000000981:diagnostic imaging*; D011756:Diphosphates; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D004369:Pentetic Acid; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013318:Stroke Volume; D013667:Technetium; D016284:Technetium Tc 99m Pentetate; D016698:Technetium Tc 99m Pyrophosphate; D013793:Thallium
D011756:Diphosphates; D011868:Radioisotopes; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium; D004369:Pentetic Acid; D013793:Thallium; D016284:Technetium Tc 99m Pentetate